Owlet OWLT
NYSE OWLT
$5.62 -0.17 (-2.94%)
At close: Aug 20, 2026 · 2:36 PM UTC

Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026)

Owlet (OWLT) posted quarterly Net Income towards Common Stockholders of -$4.1 million for Q1 2026, down 336.96% year-over-year from $1.7 million in Q1 2025, and up 58.15% quarter-over-quarter from -$9.9 million in Q4 2025.

Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Owlet (OWLT) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$4.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 336.96% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at -$48.6 million (down 179.48% YoY), while the FY2025 annual figure was -$41.9 million, down 143.1% from the prior year.
  • Net Income towards Common Stockholders grew to -$4.1 million in Q1 2026 per OWLT's latest filing, from -$9.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $2.7 million in Q3 2025 and bottomed at -$37.2 million in Q2 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$10.7 million across 5 years, with a median of -$9.7 million in 2024.
  • On a YoY basis, Net Income towards Common Stockholders climbed as much as 139.61% in 2025 and fell as far as 1286.54% in 2025.
  • Owlet's Net Income towards Common Stockholders stood at -$19.5 million in 2022, then surged by 57.85% to -$8.2 million in 2023, then slipped by 17.8% to -$9.7 million in 2024, then retreated by 2.23% to -$9.9 million in 2025, then jumped by 58.15% to -$4.1 million in 2026.
  • Business Quant data shows OWLT's Net Income towards Common Stockholders at -$4.1 million in Q1 2026, -$9.9 million in Q4 2025, and $2.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 621.86 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 201.00 Mn
10 Owlet 160.25 Mn 123.70 Mn 21.82 Mn -1.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.47 Mn
Mar 31, 2026 -4.14 Mn
Dec 31, 2025 -9.90 Mn
Sep 30, 2025 2.68 Mn
Jun 30, 2025 -37.19 Mn
Mar 31, 2025 1.75 Mn
Dec 31, 2024 -9.68 Mn
Sep 30, 2024 -6.76 Mn
Jun 30, 2024 -2.68 Mn
Mar 31, 2024 1.29 Mn
Dec 31, 2023 -8.22 Mn
Sep 30, 2023 -6.96 Mn
Jun 30, 2023 -9.79 Mn
Mar 31, 2023 -12.52 Mn
Dec 31, 2022 -19.50 Mn
Sep 30, 2022 -19.36 Mn
Jun 30, 2022 -11.72 Mn
Mar 31, 2022 -28.76 Mn
Dec 31, 2021 -24.06 Mn
Sep 30, 2021 -34.46 Mn